Heather Preuss, MD
Family Medicine · Hot Springs, SDNPI 1013028422
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $721 and has fallen 64.2% since, to $258 in 2025. Among family medicine clinicians in SD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $16.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$286
- AstraZeneca$276
- Amgen$266
- Lilly USA, LLC$216
- Boehringer Ingelheim$212
- Pfizer$154
- plus $715 from 13 others
What the payments were for
- Food & beverage$2,125100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $286 |
| AstraZeneca | 10 | $276 |
| Amgen | 19 | $266 |
| Lilly USA, LLC | 11 | $216 |
| Boehringer Ingelheim | 14 | $212 |
| Pfizer | 11 | $154 |
| AbbVie | 7 | $152 |
| Johnson & Johnson | 10 | $138 |
| Novartis | 4 | $75 |
| Sanofi-aventis U.S. LLC | 4 | $72 |
| Merck | 5 | $64 |
| GSK | 4 | $54 |
| Exact Sciences | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Avanir Pharmaceuticals, Inc. | 2 | $28 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Philips North America LLC | 1 | $18 |
| Bayer | 1 | $15 |
| Eisai Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$116
How this compares
$2,125 in reported general payments places this provider in the 90th percentile of 408 family medicine providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 123 | $119,895 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 62 | $68,619 |
| JardianceEmpagliflozin | 52 | $43,284 |
| OzempicSemaglutide | 18 | $39,933 |
| XareltoRivaroxaban | 26 | $29,381 |
| RybelsusSemaglutide | 12 | $28,282 |
| TrulicityDulaglutide | 19 | $21,880 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 21 | $15,161 |
| FarxigaDapagliflozin Propanediol | 12 | $11,236 |
| TradjentaLinagliptin | 17 | $8,233 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 25 | $8,129 |
| MounjaroTirzepatide | 11 | $8,094 |
| JanuviaSitagliptin Phosphate | 12 | $7,583 |
| OxycontinOxycodone Hcl | 22 | $7,559 |
| Spiriva RespimatTiotropium Bromide | 13 | $7,314 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo | $154 | $128,024148 claims |
| GSKTrelegy Ellipta, Shingrix, Arnuity Ellipta | $54 | $79,019103 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Tradjenta, Spiriva Respimat | $212 | $73,992103 claims |
| Novo NordiskOzempic, Rybelsus | $286 | $68,21530 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $216 | $29,97430 claims |
| Johnson & JohnsonXarelto | $138 | $29,38126 claims |
| AstraZenecaFarxiga, Brilinta, Symbicort, Pulmicort Flexhaler | $276 | $25,44048 claims |
| MerckJanuvia | $64 | $7,58312 claims |
| AbbVieSynthroid | $152 | $5,69797 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 408 family medicine providers in South Dakota.
Other family medicine in Hot Springs
- Avery SidesHot Springs$1K
- Kyla Helm-SwansonRapid City$22K
- Andrew BurchettSioux Falls$13K
- Lornell HansenSioux Falls$11K
- Michael GerlachMitchell$9K
- Jeffry MeyerSioux Falls$8K
- Scott BoyensSioux Falls$6K
- Terry GraberCuster$6K
- Christi ChildersSpearfish$6K
- Jonathan McAreaveyWatertown$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.